Mitchell E. Levinson - 07 Oct 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Chief Strategy Officer, Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
07 Oct 2022
Net transactions value
+$69,908
Form type
4
Filing time
11 Oct 2022, 19:11:46 UTC
Previous filing
10 Jun 2022
Next filing
09 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $20,083 +8,770 +23% $2.29 46,274 07 Oct 2022 Direct
transaction PLSE Common Stock Purchase $19,999 +8,810 +213% $2.27 12,945 07 Oct 2022 Spouse
transaction PLSE Common Stock Purchase $9,944 +4,400 +599% $2.26 5,134 07 Oct 2022 Immediate family member
transaction PLSE Common Stock Purchase $10,035 +4,500 +613% $2.23 5,234 07 Oct 2022 Immediate family member
transaction PLSE Common Stock Purchase $9,847 +4,300 +586% $2.29 5,034 07 Oct 2022 Immediate family member
* An asterisk sign (*) next to the price indicates that the price is likely invalid.